Researchers are continuing to explore how cerebral cavernous malformations (CCM) develop and behave at a cellular level. In a recent study, scientists used organoids, which are miniature 3D tissues grown in a lab that mimic the structure and function of real human tissue. Organoids allow researchers to study complex biological processes in a controlled environment that closely reflects what happens in the human body.
In this work, researchers from the Greifswald lab, which is part of the Alliance to Cure Cavernous Malformation’s CureDriver initiative, used blood vessel organoids to better understand the roles of CCM proteins. Their findings help clarify how these proteins function individually and together, providing important insight that may support future therapeutic development.
Research Overview for a General Audience
Original Scientific Journal Article
